↓ Skip to main content

Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer

Overview of attention for article published in Frontiers in immunology, August 2023
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer
Published in
Frontiers in immunology, August 2023
DOI 10.3389/fimmu.2023.1193040
Pubmed ID
Authors

Yangyang Ma, Yanli Xing, Hongmei Li, Ting Yuan, Bing Liang, Rongrong Li, Jianyu Li, Zhonghai Li, Shuying Li, Lizhi Niu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 14%
Student > Bachelor 1 14%
Other 1 14%
Student > Doctoral Student 1 14%
Student > Master 1 14%
Other 0 0%
Unknown 2 29%
Readers by discipline Count As %
Unspecified 1 14%
Biochemistry, Genetics and Molecular Biology 1 14%
Immunology and Microbiology 1 14%
Chemistry 1 14%
Medicine and Dentistry 1 14%
Other 0 0%
Unknown 2 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2023.
All research outputs
#21,608,491
of 26,523,931 outputs
Outputs from Frontiers in immunology
#25,963
of 33,350 outputs
Outputs of similar age
#265,718
of 365,730 outputs
Outputs of similar age from Frontiers in immunology
#913
of 1,218 outputs
Altmetric has tracked 26,523,931 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,350 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,730 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,218 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.